
Partner, Cooley LLP
Matthew Browne
Matt Browne’s practice focuses on transactional and general corporate matters, with Matt typically serving as his client’s first point of contact at Cooley for all matters and regularly working with them on mergers and acquisitions, public and private securities offerings, public company reporting and disclosure issues, corporate governance matters and other commercial matters. Matt also has expertise in the drug royalty space, having advised clients on numerous drug royalty transactions involving many different transaction structures and with aggregate proceeds in excess of $2.3 billion.